PTSD Trial, Recruiting NCT06494319 Sponsor: The University of Texas Health Science Center, Houston Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT06494319
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are current or former members of the US Military (Veterans or active Service Members)
  • People who have been assessed with PTSD, shown by a score above 33 on a standard PTSD checklist (PCL-5)
  • People who have experienced combat trauma or served in a location that qualified for imminent danger pay
  • People who are fluent in English
  • People who are able to read, understand, and sign a consent form agreeing to the study's requirements
  • People who have access to a smartphone or tablet, to use a mobile health app or join a virtual classroom
  • People who are willing to complete psychological questionnaires and ongoing assessments throughout the study
  • People who are able to complete all assessments independently, are willing to follow all study procedures, and are available for the full duration of the study

Who may not be able to join:

  • People who are currently experiencing active thoughts of suicide, as identified by the study investigator at screening or at any point during the study
  • People with a significant history of psychotic disorder, bipolar disorder, or a brain/memory-related condition such as dementia, as determined by the study investigator
  • People with serious, active substance misuse — including an alcohol use score above 15 on a standard screening tool, or reported use of illicit substances other than cannabis, or cannabis use three or more times per week (confirm with trial site)
  • People who are currently receiving another form of treatment more than twice a month, other than general supportive therapy
  • People who are currently engaged in specific trauma-focused therapies, including Cognitive Processing Therapy (CPT), Prolonged Exposure (PE), or Eye Movement Desensitization and Reprocessing (EMDR)
  • People where the study investigator believes participation could affect the person's safety or the quality of the study results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sarah Jackson, PhD, The University of Texas Health Science Center, Houston

Phone: (281) 825-9923

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 May 2024
Est. completion
30 June 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reduced symptoms of PTSD as assessed by the Posttraumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (PCL-5); Increasing resilience as assessed by The Connor-Davidson Resilience Scale-10 (CD-RISC-10)4; Satisfaction with care as assessed by the Client Satisfaction Questionnaire-8-item (CSQ-8); Satisfaction with care as assessed by the Client Satisfaction Questionnaire-8 item ( CSQ-8); Satisfaction with care as assessed by the Client Satisfaction Questionnaire (8-item; CSQ-8); Change in average heart rate as assessed by the emWave Inner Balance pe...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov